Bausch Health Companies (BHC) Assets Average (2010 - 2026)
Bausch Health Companies' (BHC) quarterly Assets Average came in at $24.6 billion in Q2 2026, down 8.19% year-over-year from $26.8 billion in Q2 2025, and down 3.09% quarter-over-quarter from $25.4 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Assets Average (2010 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Assets Average across 17 years of filings, most recently posting $24.6 billion for Q2 2026.
- In Q2 2026, Assets Average fell 8.19% year-over-year to $24.6 billion; the TTM figure through Jun 2026 stood at $24.6 billion (down 8.19% YoY), while the FY2025 annual figure was $26.4 billion, down 1.83% from the prior year.
- Assets Average came in at $24.6 billion for Q2 2026 at Bausch Health Companies, down from $25.4 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $29.1 billion in Q1 2022 to a low of $24.6 billion in Q2 2026.
- Average Assets Average over 5 years is $26.6 billion, with a median of $26.6 billion recorded in 2024.
- Year-over-year, Assets Average dropped 12.28% in 2023 and climbed 6.13% in 2024.
- Over 5 years, Assets Average stood at $26.0 billion in 2022, then gained by 4.67% to $27.2 billion in 2023, then decreased by 2.48% to $26.5 billion in 2024, then gained by 0.24% to $26.6 billion in 2025, then slipped by 7.33% to $24.6 billion in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $24.6 billion in Q2 2026, $25.4 billion in Q1 2026, and $26.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 39.95 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 35.94 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.21 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.66 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 24.65 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.50 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.46 Bn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.70 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 73.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 21.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.65 Bn |
| Mar 31, 2026 | 25.43 Bn |
| Dec 31, 2025 | 26.60 Bn |
| Sep 30, 2025 | 27.05 Bn |
| Jun 30, 2025 | 26.84 Bn |
| Mar 31, 2025 | 26.47 Bn |
| Dec 31, 2024 | 26.53 Bn |
| Sep 30, 2024 | 26.52 Bn |
| Jun 30, 2024 | 26.70 Bn |
| Mar 31, 2024 | 27.13 Bn |
| Dec 31, 2023 | 27.21 Bn |
| Sep 30, 2023 | 26.28 Bn |
| Jun 30, 2023 | 25.47 Bn |
| Mar 31, 2023 | 25.57 Bn |
| Dec 31, 2022 | 25.99 Bn |
| Sep 30, 2022 | 27.23 Bn |
| Jun 30, 2022 | 28.63 Bn |
| Mar 31, 2022 | 29.15 Bn |
| Dec 31, 2021 | 29.23 Bn |
| Sep 30, 2021 | 29.65 Bn |